Nadiifinta Creatinine
Hab-xisaabeedka Cockcroft-Gault
Natiijada
Qiyaasta Nadiifinta Creatinine (CrCl)
Kala Soocidda:
Heerka (qiyaas ahaan):
Fiiro gaar ah: CrCl ≥ 60 mL/min, hab-xisaabeedka Cockcroft-Gault wuxuu u badan yahay inuu sare u qiyaaso shaqada kelyaha. Kala soocidda CKD heerkan gudihiisa waa mid saxsan marka la isticmaalo CKD-EPI ama MDRD. Xaqiiji hab-xisaabeed kale haddii xaaladda caafimaad ay u baahan tahay.
CrCl-ga CG kuma habeeyeyn 1.73 m² — kala soocidda KDIGO waa qiyaas
Kala Soocidda Shaqada Kelyaha
Ku salaysan heerarka KDIGO. CrCl-ga CG kuma habeeyeyn 1.73 m²; kala soocidda waa qiyaas.
| CrCl (mL/min) | Kala Soocidda | Heerka |
|---|---|---|
| ≥ 90 | Caadi ama sare | G1 |
| 60 – 89 | Hoos u dhac yar | G2 |
| 45 – 59 | Hoos u dhac yar ilaa dhexdhexaad | G3a |
| 30 – 44 | Hoos u dhac dhexdhexaad ilaa daran | G3b |
| 15 – 29 | Hoos u dhac daran | G4 |
| < 15 | Fashilka kelyaha | G5 |
Ku Saabsan Hab-xisaabeedka Cockcroft-Gault
Hab-xisaabeedka
CrCl (mL/min) = [(140 − da'da) × miisaanka] / (72 × creatinine seerumka)
Bukaanada dheddigga ah: ku dhufo natiijada 0.85
Isticmaalka Caafimaad
Isticmaalka ugu weyn ee hab-xisaabeedka Cockcroft-Gault waa habeynta jaraya daawooyinka ee daawooyinka intiisa badan ka soo baxa kelyaha (antibiyootiga, daawooyinka dhiig-fadhiga, daawooyinka sokorow, iyo kuwa kale). Dukumeenti badan oo macluumaadka alaabada daawada ah iyo hagayaal daawo ah ayaa ku salaynaya shuruudaha habeynta jaraya hab-xisaabeedkan. Kala soocidda CKD, MDRD ama CKD-EPI ayaa la doorbidaa.
Miisaanka la isticmaali doono — tixgelin muhiim ah
Hab-xisaabeedkii asalka ahaa waxaa lagu soo saaray dad aan badnayn oo buurbuuran. Bukaanada buurbuuran, isticmaalka miisaanka dhabta ah wuxuu sare u qiyaasaa CrCl. Ku-dhaqanka la talinayo:
- • Miisaanka dhabta ah (ABW): marka aysan jirin buurbuuran muhiim ah
- • Miisaanka la rabo (IBW): Lab = 50 + 0.91 × (dherarka cm − 152.4); Dheddig = 45.5 + 0.91 × (dherarka cm − 152.4)
- • Miisaanka la habeeyay (AdjBW): IBW + 0.4 × (ABW − IBW) — waxaa la talinayaa marka ABW ay ka badan tahay %120 ee IBW
Xayiraadaha
Wuxuu u badan yahay sare u qiyaasa CrCl bukaanada waaweyn, dadka buurbuuran, iyo kuwa leh muruq yar (cachexia, gooyaha jirka). Uma habboona bukaanada dialysis-ka qaadanaya, kuwa shaqada kelyahoodu si degdeg ah u beddelanayso, ama kuwa xagga muruqa ku fog. Kuma habeyneyn 1.73 m².
Fiiro gaar ah: Kalkuleytarkani wuxuu bixiyaa qiyaas CrCl ah. Natiijada waa in lagu fasiro macnaha caafimaad ee bukaanka, oo ay ku jiraan xaaladda biyaha jidhka, muruqa, iyo xasilloonida shaqada kelyaha. Bukaanada buurbuuran, geli miisaanka la rabo ama la habeeyay si aan loo sare qiyaasin. Kalkuleytarkani kama beddelayo qiimeynta caafimaad ee shakhsi ahaaneed.
Tixraacyada
- 1. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. PubMed ↗
- 2. Winter MA, Guhr KN, Berg GM. Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation. Pharmacotherapy. 2012;32(7):604–612. PubMed ↗